Skip to main content
Clinical Trials/NCT04033575
NCT04033575
Completed
Phase 4

Clinical Investigation of a Toothpaste Containing Stannous Fluoride as Compared to Colgate Fluoride Toothpaste in Reducing Plaque and Gingivitis - a Three Month Study

Colgate Palmolive1 site in 1 country88 target enrollmentMarch 6, 2019

Overview

Phase
Phase 4
Intervention
Colgate Cavity Protection toothpaste
Conditions
Gingivitis
Sponsor
Colgate Palmolive
Enrollment
88
Locations
1
Primary Endpoint
Gingivitis Scores
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The objective of this study is to evaluate the clinical efficacy of a toothpaste containing stannous fluoride as compared to Colgate Fluoride Toothpaste in reducing plaque and gingivitis - a three- month study.

Detailed Description

This was a 6-month, randomized, single-center, parallel group, double-blinded, clinical research study to assess the clinical efficacy of two toothpastes containing stannous fluoride (SnHW and CPH) as compared to Regular Fluoride Toothpaste on the reduction of established dental plaque and gingivitis in adults.

Registry
clinicaltrials.gov
Start Date
March 6, 2019
End Date
July 1, 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects, ages 18-70, inclusive.
  • Availability for the six-month duration ofthe clinical research study.
  • Good general health.
  • Minimum of 20 uncrowned permanent natural teeth (excluding third molars).
  • Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
  • Initial plaque index of at least 1.5 as determined by the use of the Quigley and Hein °Plaque Index (Turesky Modification).
  • Signed Informed Consent Form.

Exclusion Criteria

  • Presence of partial denture.
  • Presence of partial removable dentures.
  • Tumor(s) of the soft or hard tissues of the oral cavity.
  • Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone).
  • Five or more carious lesions requiring immediate restorative treatment.
  • Antibiotic use any time during the one month prior to entry into the study.
  • Participation in any other clinical study or test panel within the one month prior to entry into the study.
  • Dental prophylaxis during the past two weeks prior to baseline examinations.
  • History of allergies to oral care/personal care consumer products or their ingredients.
  • On any prescription medicines that might interfere with the study outcome.

Arms & Interventions

Fluoride Control

Colgate Cavity Protection 0.76% as Na MFP Toothpaste

Intervention: Colgate Cavity Protection toothpaste

Colgate Total SF

Colgate Total Clean Mint White Paste 1100 ppm F Toothpaste

Intervention: Colgate Total SF

Outcomes

Primary Outcomes

Gingivitis Scores

Time Frame: 3 months

Gingivitis scale (Loe \& Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)

Dental Plaque Score

Time Frame: 3 months

Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)

Study Sites (1)

Loading locations...

Similar Trials